CLINICAL FEATURES AND TYPES OF VON WILLEBRAND DISEASE IN WOMEN WITH MENORRHAGIA REFERRED TO HEMATOLOGY CLINIC OF KERMANSHAH

EHA Library, Mehrnoush Aeinfar, 216831

COMBINED ORAL ADMINISTRATION OF ANALGESIA AND ANXIOLYSIS FOR PAIN ASSOCIATED WITH BONE MARROW ASPIRATION AND BIOPSY

EHA Library, Claudio Cerchione, 216878

ACTIONS THAT MAKE ANTICOAGULANT THERAPY SAFER: 10 YEARS ON - DO WE COMPLY? EVALUATING WARFARIN USE AND APPROPRIATENESS AT A LONDON ACUTE HOSPITAL

EHA Library, Drew Harding, 216877

COST OF HEMATOLOGIC CANCERS IN INDIA: A HOSPITAL INPATIENT CARE ANALYSIS

EHA Library, Chepsy Cherian Philip, 216876

PHARMACOECONOMIC EVALUATION OF MANAGEMENT OF DASATINIB AND IMATINIB THERAPY SIDE EFFECTS IN CHRONIC MYELOID LEUKEMIA. MULTICENTRIC RETROSPECTIVE STUDY.

EHA Library, GIULIO GIORDANO, 216875

EVALUATION OF FERRIC MALTOL AS ALTERNATIVE TO PARENTERAL IRON THERAPY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD) IN TERMS OF COSTS REDUCTIONS AND HEALTHCARE HUMAN RESOURCE UTILISATION

EHA Library, Silvia Lovato, 216874

THE OTHER SIDE OF THE MOON: PATIENTS’ PERCEPTION OF IMATINIB AND DASATINIB SYMPTOM BURDEN FOR CHRONIC MYELOID LEUKEMIA. RESULTS OF THE PATIENT’S JOURNEY FROM THE REAL-LIFE SOLARIS PROJECT

EHA Library, Fabio Stagno, 216873

STRONG ASSOCIATION BETWEEN HERPES SIMPLEX VIRUS AND CHEMOTHERAPY-INDUCED ORAL MUCOSITIS IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES UNDERGOING INTENSIVE CHEMOTHERAPY OR STEM CELL TRANSPLANTATION

EHA Library, Junshik Hong, 216872

HEALTH-RELATED QUALITY OF LIFE IN CAREGIVER OF HEMOPHILIA PATIENTS

EHA Library, Gonzalo Ferrer Garrido, 216871

KNOWLEDGE, CULTURAL, AND STRUCTURAL BARRIERS TO THALASSEMIA SCREENING IN MIGRANT POPULATIONS IN THAILAND

EHA Library, Julia Xu, 216870

PREVALENCE OF ANXIETY AND DEPRESSION AMONG CAREGIVERS OF CANCER PATIENTS IN MALAYSIA

EHA Library, Kevin Tey Wen Fei, 216869

PROFILE OF "OLDEST OLD" PATIENTS WITH ANEMIA IN A HEMATOLOGY-GERIATRIC INTERDISCIPLINARY CONSULTATION.

EHA Library, Laura Lacalle, 216868

TIME FROM SYMPTOM ONSET TO DIAGNOSIS AND TREATMENT AMONG HEMATOLOGICAL MALIGNANCIES: DISEASE, PATIENT AND HEALTH SYSTEM RELATED INFLUENCING FACTORS

EHA Library, Austėja Dapkevičiūtė, 216867

PREVALENCE OF METABOLIC SYNDROME AND SARCOPENIA AS LONG-TERM LATE EFFECTS IN LYMPHOMA SURVIVORS

EHA Library, Antonella Daniele, 216866

MONTELUKAST AND GEMFIBROZIL IMPROVES SYMPTOM CONTROL AND ENHANCES THE RESPONSE TO ORAL CHEMOTHERAPY IN HAEMATOLOGICAL MALIGNANCIES WITH A POOR PROGNOSIS.

EHA Library, Stephen O'Mara, 216865

RESULTS OF A MULTICENTER UNIVERSAL NEWBORN SCREENING PROGRAM FOR SICKLE CELL DISEASE IN ITALY: A CALL TO ACTION

EHA Library, R Colombatti, 216864

TREATMENT PATTERN AND UNMET NEED IN ADULTS WITH PHILADELPHIA POSITIVE (PH+) RELAPSED OR REFRACTORY (R/R) B-CELL PRECURSOR (BCP) ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) IN EU-5 COUNTRIES.

EHA Library, Xinke Zhang, 216863

TERTIARY PREVENTION FOR PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Pavel Kotoucek, 216862

A REVIEW OF CLINICAL PRACTICE REGARDING DNACPR DECISION MAKING, DISCUSSION AND IMPLEMENTATION

EHA Library, Anneka Burge, 216861

REAL‐WORLD UTILIZATION OF MULTIPLE MYELOMA TREATMENTS IN THE ERA OF NOVEL THERAPIES: WHAT IS THE CURRENT STANDARD OF CARE?

EHA Library, Eric Maiese, 216860

REFERRALS TO HEMATOLOGICAL CONSULTATIONS FOR EOSINOPHILIA – DIFFERENCES BETWEEN GENERAL AND UNIVERSITY HOSPITAL PATIENTS.

EHA Library, Hrvoje Holik , 216859

QUALITATIVE STUDY INVESTIGATING THE PERCEPTIONS OF MYELOPROLIFERATIVE NEOPLASM PATIENTS PARTICIPATING IN AN ONLINE YOGA INTERVENTION

EHA Library, Jennifer Huberty, 216858

INFLUENCE OF ABO BLOOD GROUP ON VON WILLEBRAND FACTOR TESTS IN HEALTHY SAUDI BLOOD DONORS

EHA Library, Salwa Bakr, 216857

QUALITY OF LIFE OF PATIENTS WITH TYPE 1 GAUCHER DISEASE AFTER LONG-TERM ENZYME REPLACEMENT THERAPY

EHA Library, Hongmin Li, 216856

METABOLIC PROFILE OF CHILDREN AND ADOLESCENTS FOLLOWING TREATMENT FOR HEMATOLOGIC MALIGNANCIES

EHA Library, Despoina Apostolaki, 216855

QUALITY OF LIFE OF TRANSFUSION DEPENDENT THALASSEMIA PATIENTS IN GREECE. A MULTICENTRE STUDY

EHA Library, Philippos Klonizakis, 216854

TEACHING HAEMATOLOGY TO MEDICAL STUDENTS: WHAT DO WE TEACH AND WHAT THEY WANT TO BE TAUGHT

EHA Library, Silvia Lovato, 216853

NEPA (NETUPITANT PLUS PALONOSETRON) FOR THE PREVENTION OF CHEMOTHERAPY INDUCED NAUSEA AND VOMITING IN PATIENTS RECEIVING STEM CELL TRANSPLANTATION

EHA Library, Mariana Corrochano, 216852

MYELOPROLIFERATIVE NEOPLASMS AND ACCEPTANCE AND COMMITMENT THERAPY: AN ONGOING FEASIBILITY STUDY AIMED AT SYMPTOM MITIGATION AND QUALITY OF LIFE

EHA Library, Leslie Padrnos, 216851

KNOWLEDGE ATTITUDE AND PRACTICE OF BLOOD DONATION AMONGST MEDICAL STUDENTS IN NIGERIA

EHA Library, Chilota Efobi, 216810

NON –CATHATER THROMBOEMBOLIC EVENTS IN CHILDREN

EHA Library, Zafer Salcioglu, 216811

GENETIC MUTATION WITH BAT SCORING ASSESSMENT IN GLANZMANN THROMBASTHENIA PATIENTS

EHA Library, Madiha Abid, 216812

IMMUNE MEDIATED THROMBOCYTOPAENIA IN CHILDREN: WHAT HAPPENS AFTER THE REFERRAL? : A 7 YEAR RETROSPECTIVE REVIEW IN A TERTIARY PAEDIATRIC HAEMATOLOGY CENTRE

EHA Library, Rincy Koshy, 216813

IMMUNE THROMBOCYTOPENIA AND VITAMIN D DEFICIENCY

EHA Library, Christopher Tham, 216814

PERIOPERATIVE USE OF ELTROMBOPAG IN PATIENTS WITH CHRONIC THROMBOCYTOPENIA . A SINGLE-CENTER EXPERIENCE

EHA Library, Elena Landete, 216815

LONG-TERM ELTROMBOPAG IN PEDIATRIC PATIENTS WITH CHRONIC IMMUNE THROMBOCYTOPENIA (CITP): AN EXTENSION STUDY OF RUSSIAN PATIENTS FROM PETIT2

EHA Library, Elena Donyush, 216816

CLINICAL AND LABORATORY PARAMETERS IN CHILDREN WITH ITP

EHA Library, Osama TANOUS, 216817

ADULT PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA (ITP) TREATED WITH THROMBOPOIETIN RECEPTOR AGONISTS: A RETROSPECTIVE STUDY USING DATA FROM THE ITP REGISTRY OF THE HELLENIC SOCIETY OF HEMATOLOGY

EHA Library, Charalampos Pontikoglou, 216818

WASP MUTATIONS: A SINGLE GENE DEFECT, LEADING TO VARIOUS CLINICAL AND HEMATOLOGICAL PHENOTYPES

EHA Library, Katayoun Kiaras, 216819

THE USEFULNESS OF THE IMMATURE PLATELET FRACTION IN THE DIAGNOSIS OF ITP AND OTHER HEMATOLOGIC DISEASES.

EHA Library, Dong Jin Park, 216820

DISCONTINUATION OF TREATMENT WITH TROMBOPOIETIN RECEPTOR ANALOGS IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA (ITP): IS IT POSSIBLE?

EHA Library, Maria Yuste Platero, 216821

UNIQUE CASE OF TYPE 3 VON WILLEBRAND DISEASE

EHA Library, Mamatha mandava, 216822

RETROSPECTIVE EVALUATION OF ACQUIRED HEMOPHILIA IN A SPANISH CENTER

EHA Library, Fernando Martin Moro, 216823

CYTOKINE ADSORPTION IN A PATIENT WITH SEVERE COAGULATION ABNORMALITIES DUE TO HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS (HLH)

EHA Library, Sebastian Birndt, 216824

THE ASSOCIATION BETWEEN HLA CLASS I,II ALLELES AND THE OCCURRENCE OF INHIBITOR IN TURKISH PATİENTS WITH HEMOPHILIA A: A PILOT STUDY

EHA Library, Turkan Patıroglu, 216825

COMPARISON BETWEEN ELISA BASED TEST FOR DETECTION OF FACTOR VIII ANTIBODIES SCREEN AND STANDARD BETHESDA

EHA Library, Salwa Bakr, 216826

HEMOPHILIA CARE IN PAKISTAN

EHA Library, Munira Borhany, 216827

TRAINING THE PATENT AND PARENTS IN SELF - ADMINISTERING THE MISSING BLOOD FACTOR AT HOME.

EHA Library, Pawel Laguna, 216828

CONTINUOUS INFUSION OF TUROCTOCOG ALFA DURING SURGERY: AN EFFECTIVE AND SAFE WAY OF TREATING PATIENTS WITH HAEMOPHILIA A

EHA Library, Laurien Koers, 216829

A RARE CASE OF ACQUIRED HEMOPHILIA A INDUCED BY THE USE OF RIVAROXABAN

EHA Library, Camila Freitas de Andrade Rodrigues, 216830

GENERAL HEALTH IN OLDER ADULTS WITH NON-HODGKIN LYMPHOMA USING A COMPREHENSIVE GERIATRIC ASSESSMENT

EHA Library, Daniel Mercante, 216850

KOREAN VON WILLEBRAND DISEASE REALITIES

EHA Library, Sang Kyu Park, 216832

INCORPORATION OF EVIDENCE BASED GUIDELINES ON BLEEDING RISK ASSESSMENT PRIOR TO ENT SURGERY INTO PRACTICE: REAL TIME EXPERIENCE

EHA Library, Manar Maktoom, 216833

UNDERLYING DISEASE OF THE ACQUIRED HAEMOPHILIA AFFECTS THE TREATMENT OUTCOME AND PROGNOSIS – CROATIAN EXPERIENCE

EHA Library, Marijo Vodanovic, 216834

GENETIC FACTORS POSSIBLY CONTRIBUTING TO COMPLICATIONS AFTER ORTHOPEDIC OPERATIONS IN HEMOPHILIA PATIENTS

EHA Library, Tatiana Polyanskaya, 216835

CHANGE OF FIBRINOGEN LEVEL AND ACTIVITY OF FXIII UNDER THE INFLUENCE OF THE REGULATORY PEPTIDES PRO-GLY-PRO AND PRO-GLY-ARG.

EHA Library, Tamara Obergan, 216836

RITUXIMAB FOR REFRACTORY THROMBOTIC THROMBOCYTOPENIC PURPURA IN CRITICALLY ILL PATIENT

EHA Library, Shehab Fareed Abdelgabber, 216837

ANTITHROMBOTIC ACTIVITY OF PEPTIDE SELANK AGAINST THE BACKGROUND OF EXPERIMENTALLY INDUCED ENDOTHELIAL DYSFUNCTION IN RATS

EHA Library, Elina Rogozinskaya, 216838

MAY-THURNER SYNDROME AND RECURRENT DEEP VENOUS THROMBOSIS IN TWO PEDIATRIC CASE TREATED WITH DABIGATRAN ETEXILATE

EHA Library, Selin Aytac, 216839

ACTIVATION OF PLATELET HAEMOSTASIS AND ITS CORRECTION BY PROLINE-CONTAINING PEPTIDES IN METABOLIC DISORDERS

EHA Library, Marina Grigorjeva, 216840

THE ELEVATION OF VON WILLEBRAND FACTOR (VWF) IN THE PATIENTS WITH MALIGNANT LYMPHOMA TREATED WITH RITUXIMAB (R)-CHOP THERAPY

EHA Library, Naomi Shimizu, 216841

MULTI-ORGAN THROMBOSIS AS A MANIFESTATION OF IDIOPATHIC HYPEREOSINOPHILIC SYNDROME IN A CHILD – A CASE REPORT

EHA Library, Sapna Oberoi, 216842

THROMBOLYTİC TREATMENT IN A CHILD WITH OF DIFFUSE VENOUS THROMBOSIS: BEHCET'S DISEASE

EHA Library, Sema AYLAN GELEN, 216843

LEICINE-CONTAINING REGULATORY PEPTIDES PREVENT THE DEVELOPMENT OF TROMBOSIS

EHA Library, Ludmila Lyapina, 216844

DEEP VEIN THROMBOSIS IN THE INPATIENT : A TERTIARY CARE ANALYSIS FROM INDIA

EHA Library, Chepsy Cherian Philip, 216845

PLASMA LEVELS OF SOME HEMOSTATIC MARKERS IN PATIENTS WITH ACUTE CORONARY SYNDROMES

EHA Library, Yuliya Tyravska, 216846

GENETIC POLYMORPHISMS AS RISK FACTORS OF ENDOTHELIAL DYSFUNCTION IN PREGNANT WOMEN

EHA Library, Natalia Korsakova, 216847

PAIN AND SERIOUS ADVERSE EVENT WITH BONE MARROW ASPIRATION AND BIOPSY: A SINGLE CENTRE EXPERIENCE FROM INDIA

EHA Library, Chepsy Cherian Philip, 216848

THE CHANGE OF QUALITY OF LIFE IN 52 NON-SEVERE APLASTIC ANEMIA PATIENTS AFTER CYCLOSPORINE A THERAPY

EHA Library, Fangfei Chen, 216849

EHA23 Educational Updates in Hematology

EHA Library, EHA annual congress, 219399

EHA23 Abstract Book

EHA Library, EHA annual congress, 219320

TLS risk assessment with CLL therapies

EHA Library, John Gribben, 209967

TLS prophylaxis and monitoring

EHA Library, John Seymour, 209966

Clinical management of TLS

EHA Library, Barbara Eichhorst, 209965

A challenging course through a difficult landscape

EHA Library, Delivered by Janssen, 205759

HME FORUM The Clinical Implications of Our Improved Understanding Of CLL Biology

EHA Library, Delivered by Janssen, 202872

HME FORUM Optimizing Outcomes For Patients With CLL

EHA Library, Delivered by Janssen, 202871

Emerging treatment goals in chronic myeloid lymphoma

EHA Library, Delivered by Novartis, 202870

Registration form for mentors

EHA Library, Course Faculty, 196305

Treatment of Patients With Myelofibrosis and Uncontrolled Polycythemia Vera

EHA Library, Delivered by Novartis, 193789

ITP and AA: Our current understanding and what the future might hold

EHA Library, Delivered by Novartis, 192923

From biology to targeted therapies in chronic lymphocytic leukemia

EHA Library, Stephan Stilgenbauer, 184561

Hemophilia Treatment: Navigating Speed Bumps on the Innovation Highway

EHA Library, Donna DiMichele, 184560

INDUCTION OF HEMOGENIC REPROGRAMMING IN HUMAN FIBROBLASTS

EHA Library, Andreia Gomes, 183930

Managing CLL patients after BCR inhibitor failure

EHA Library, Jeffrey Jones, 184553

Harnessing T cells for Immunotherapy of AML

EHA Library, Marion Subklewe, 184556

New Treatment Approaches In Myeloma In 2017

EHA Library, Jesús San Miguel, 184549

Treatment Of Aggressive Lymphoma Focused On Elderly Patients

EHA Library, Michael Pfreundschuh, 184545

New drugs for old? What is the role of B-cell receptor pathway inhibition in the front line therapy of CLL in 2017?

EHA Library, Stephen Devereux, 184552

CRYPTIC INSERTIONS OF IMMUNOGLOBULIN LIGHT CHAIN ENHANCER REGIONS ACTIVATE CCND3 AND CCND2 IN CYCLIN D1-NEGATIVE MANTLE CELL LYMPHOMAS

EHA Library, Silvia Bea, 183929

Role of enhancers in the pathogenesis of AML

EHA Library, Ruud Delwel, 184555

First-line therapy for CLL in 2017

EHA Library, Alessandra Tedeschi, 184551

Genetic Classification Of Myeloma For Prognostication And Treatment Selection

EHA Library, Hervé Avet-Loiseau, 184548

Relapsed aggressive lymphoma: Can we optimize the therapy

EHA Library, Gilles Salles, 184544

ANTI-CD69 MAB TREATMENT INCREASES THE CAPACITY OF NK CELLS TO ELIMINATE HYPER-REACTIVE ALLOGENIC T CELLS AND PREVENTS ACUTE GRAFT VERSUS HOST DISEASE

EHA Library, Katerina Tsilingiri, 183933

BONE MARROW SITES DIFFERENTLY IMPRINT DORMANCY AND CHEMORESISTANCE TO T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Francoise Pflumio, 183931

Iron Chelation in Hemoglobinopathies 

EHA Library, Vip Viprakasit, 192910

ARNT/HIF-1BETA LINKS POOR CLINICAL OUTCOME TO MICROENVIRONMENTAL HYPOXIA AND HIGH-RISK 1Q GAIN IN MULTIPLE MYELOMA

EHA Library, Fengyan Jin, 183932

The Biological Basis Of Aggressive Lymphoma

EHA Library, Elias Campo, 184543

GLOBAL PIVOTAL PHASE 2 TRIAL OF THE CD19-TARGETED THERAPY CTL019 IN ADULT PATIENTS WITH RELAPSED OR REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)—AN INTERIM ANALYSIS

EHA Library, Gilles Salles, 183934